>As indicated by the 3rd referee, the progression and therapeutic information is fine but how prognosis is studied is not clear without a follow-up data?（如何进一步对预后进行研究呢）
>
>No validation has been done for key regulatory genes in primary clinical samples.   This is essential.
>（关键调控基因需要在最初的临床样品中验证，但是纯生信的我怎么回答呢。。。）

主要聚焦这两个问题了，求帮忙解答。。。 返回小木虫查看更多